A novel rhamnose-rich hetero-exopolysaccharide isolated from Lactobacillus paracasei DG activates THP-1 human monocytic cells

Applied and Environmental Microbiology

Volumn 83, Issue 3, 2017, Pages

  Balzaretti, Silvia ^a   Taverniti, Valentina ^a   Guglielmetti, Simone ^a   Fiore, Walter ^b   Minuzzo, Mario ^a   Ngo, Hansel N ^c   Ngere, Judith B ^c   Sadiq, Sohaib ^c   Humphreys, Paul N ^c   Laws, Andrew P ^c  

^a UNIVERSITY OF MILAN   (Italy)

^b ALF X Surgical Robotics Department   (Italy)

^c UNIVERSITY OF HUDDERSFIELD   (United Kingdom)

Author keywords

Capsular EPS; Enterolactis; Immunostimulation; Lactobacillus casei DG; Lactobacillus paracasei; MAMPs; Probiotic; THP 1

Indexed keywords

BACILLI; CELL CULTURE; CELL MEMBRANES; CHEMICAL ANALYSIS; METABOLITES; NUCLEAR MAGNETIC RESONANCE;

CAPSULAR EPS; ENTEROLACTIS; IMMUNOSTIMULATION; LACTOBACILLUS CASEI; LACTOBACILLUS PARACASEI; MAMPS; PROBIOTICS; THP-1;

GENE EXPRESSION;

BACTERIUM; CELLS AND CELL COMPONENTS; ENZYME; ENZYME ACTIVITY; EXOPOLYMER; GENE EXPRESSION; GENOMICS; IMMUNE RESPONSE; IMMUNE SYSTEM; PROBIOTICS; PROTEIN; TUMOR;

BACTERIA (MICROORGANISMS); LACTOBACILLUS CASEI; LACTOBACILLUS PARACASEI;

BACTERIAL POLYSACCHARIDE; RHAMNOSE;

CELL LINE; CHEMISTRY; GENE EXPRESSION; HUMAN; LACTOBACILLUS PARACASEI; MICROBIOLOGY; MONOCYTE; PHYSIOLOGY;

CELL LINE; GENE EXPRESSION; HUMANS; LACTOBACILLUS PARACASEI; MONOCYTES; POLYSACCHARIDES, BACTERIAL; RHAMNOSE;

EID: 85010197265     PISSN: 00992240     EISSN: 10985336     Source Type: Journal    
DOI: 10.1128/AEM.02702-16     Document Type: Article

References (53)

1. D'Inca R, Barollo M, Scarpa M, Grillo AR, Brun P, Vettorato MG, Castagliuolo I, Sturniolo GC. 2011. Rectal administration of Lactobacillus casei DG modifies flora composition and Toll-like receptor expression in colonic mucosa of patients with mild ulcerative colitis. Dig Dis Sci 56: 1178-1187. https://doi.org/10.1007/s10620-010-1384-1
2. Tursi A, Brandimarte G, Giorgetti GM, Modeo ME. 2004. Effect of Lactobacillus casei supplementation on the effectiveness and tolerability of a new second-line 10-day quadruple therapy after failure of a first attempt to cure Helicobacter pylori infection. Med Sci Monit 10:CR662-CR666
3. Rosania R, Giorgio F, Principi M, Amoruso A, Monno R, Di Leo A, Ierardi E. 2013. Effect of probiotic or prebiotic supplementation on antibiotic therapy in the small intestinal bacterial overgrowth: a comparative evaluation. Curr Clin Pharmacol 8:169-172. https://doi.org/10.2174/15748847113089990048
4. Ferrario C, Taverniti V, Milani C, Fiore W, Laureati M, De Noni I, Stuknyte M, Chouaia B, Riso P, Guglielmetti S. 2014. Modulation of fecal Clostridiales bacteria and butyrate by probiotic intervention with Lactobacillus paracasei DG varies among healthy adults. J Nutr 144:1787-1796. https://doi.org/10.3945/jn.114.197723
5. Spinler JK, Taweechotipatr M, Rognerud CL, Ou CN, Tumwasorn S, Versalovic J. 2008. Human-derived probiotic Lactobacillus reuteri demonstrate antimicrobial activities targeting diverse enteric bacterial pathogens. Anaerobe 14:166-171. https://doi.org/10.1016/j.anaerobe .2008.02.001
6. Guglielmetti S, Taverniti V, Minuzzo M, Arioli S, Zanoni I, Stuknyte M, Granucci F, Karp M, Mora D. 2010. A dairy bacterium displays in vitro probiotic properties for the pharyngeal mucosa by antagonizing group A streptococci and modulating the immune response. Infect Immun 78:4734-4743. https://doi.org/10.1128/IAI.00559-10
7. Taverniti V, Stuknyte M, Minuzzo M, Arioli S, De Noni I, Scabiosi C, Cordova ZM, Junttila I, Hamalainen S, Turpeinen H, Mora D, Karp M, Pesu M, Guglielmetti S. 2013. S-layer protein mediates the stimulatory effect of Lactobacillus helveticus MIMLh5 on innate immunity. Appl Environ Microbiol 79:1221-1231. https://doi.org/10.1128/AEM.03056-12
8. Guglielmetti S, Zanoni I, Balzaretti S, Miriani M, Taverniti V, De Noni I, Presti I, Stuknyte M, Scarafoni A, Arioli S, Iametti S, Bonomi F, Mora D, Karp M, Granucci F. 2014. Murein lytic enzyme TgaA of Bifidobacterium bifidum MIMBb75 modulates dendritic cell maturation through its cysteine-and histidine-dependent amidohydrolase/peptidase (CHAP) amidase domain. Appl Environ Microbiol 80:5170-5177. https://doi.org/10.1128/AEM.00761-14
9. Hidalgo-Cantabrana C, Lopez P, Gueimonde M, de Los Reyes-Gavilan CG, Suarez A, Margolles A, Ruas-Madiedo P. 2012. Immune modulation capability of exopolysaccharides synthesised by lactic acid bacteria and bifidobacteria. Probiotics Antimicrob Proteins 4:227-237. https://doi.org/10.1007/s12602-012-9110-2
10. Ruas-Madiedo P, Gueimonde M, de los Reyes-Gavilan CG, Salminen S. 2006. Effect of exopolysaccharide isolated from "viili" on the adhesion of probiotics and pathogens to intestinal mucus. J Dairy Sci 89:2355-2358. https://doi.org/10.3168/jds.S0022-0302(06)72307-4
11. Liu CF, Tseng KC, Chiang SS, Lee BH, Hsu WH, Pan TM. 2011. Immunomodulatory and antioxidant potential of Lactobacillus exopolysaccharides. J Sci Food Agric 91:2284-2291
12. Polak-Berecka M, Wasko A, Paduch R, Skrzypek T, Sroka-Bartnicka A. 2014. The effect of cell surface components on adhesion ability of Lactobacillus rhamnosus. Antonie Van Leeuwenhoek 106:751-762. https://doi.org/10.1007/s10482-014-0245-x
13. Alhudhud M, Humphreys P, Laws A. 2014. Development of a growth medium suitable for exopolysaccharide production and structural characterisation by Bifidobacterium animalis ssp. lactis AD011. J Mi-crobiol Methods 100:93-98. https://doi.org/10.1016/j.mimet.2014 .02.021
14. Balzaretti S, Taverniti V, Rondini G, Marcolegio G, Minuzzo M, Remagni MC, Fiore W, Arioli S, Guglielmetti S. 2015. The vaginal isolate Lactobacillus paracasei LPC-S01 (DSM 26760) is suitable for oral administration. Front Microbiol 6:952. https://doi.org/10.3389/fmicb.2015.00952
15. Guglielmetti S, Tamagnini I, Minuzzo M, Arioli S, Parini C, Comelli E, Mora D. 2009. Study of the adhesion of Bifidobacterium bifidum MIMBb75 to human intestinal cell lines. Curr Microbiol 59:167-172. https://doi.org/10.1007/s00284-009-9415-x
16. Taverniti V, Guglielmetti S. 2011. The immunomodulatory properties of probiotic microorganisms beyond their viability (ghost probiotics: proposal of paraprobiotic concept). Genes Nutr 6:261-274. https://doi.org/10.1007/s12263-011-0218-x
17. Kanmani P, Satish Kumar R, Yuvaraj N, Paari KA, Pattukumar V, Arul V. 2013. Probiotics and its functionally valuable products-a review. Crit Rev Food Sci Nutr 53:641-658. https://doi.org/10.1080/10408398.2011 .553752
18. Dertli E, Mayer MJ, Narbad A. 2015. Impact of the exopolysaccharide layer on biofilms, adhesion and resistance to stress in Lactobacillus johnsonii FI9785. BMC Microbiol 15:8. https://doi.org/10.1186/s12866-015-0347-2
19. Lebeer S, Vanderleyden J, De Keersmaecker SC. 2010. Host interactions of probiotic bacterial surface molecules: comparison with commensals and pathogens. Nat Rev Microbiol 8:171-184. https://doi.org/10.1038/nrmicro2297
20. De Vuyst L, Degeest B. 1999. Heteropolysaccharides from lactic acid bacteria. FEMS Microbiol Rev 23:153-177. https://doi.org/10.1111/j.1574-6976.1999.tb00395.x
21. Ryan PM, Ross RP, Fitzgerald GF, Caplice NM, Stanton C. 2015. Sugarcoated: exopolysaccharide producing lactic acid bacteria for food and human health applications. Food Funct 6:679-693. https://doi.org/10.1039/C4FO00529E
22. Kojic M, Vujcic M, Banina A, Cocconcelli P, Cerning J, Topisirovic L. 1992. Analysis of exopolysaccharide production by Lactobacillus casei CG11, isolated from cheese. Appl Environ Microbiol 58:4086-4088
23. van Calsteren MR, Pau-Roblot C, Begin A, Roy D. 2002. Structure determination of the exopolysaccharide produced by Lactobacillus rhamnosus strains RW-9595M and R. Biochem J 363:7-17. https://doi.org/10.1042/0264-6021:3630007
24. Landersjo C, Yang Z, Huttunen E, Widmalm G. 2002. Structural studies of the exopolysaccharide produced by Lactobacillus rhamnosus strain GG (ATCC 53103). Biomacromolecules 3:880-884. https://doi.org/10.1021/bm020040q
25. Robijn GW, Wienk HL, van den Berg DJ, Haas H, Kamerling JP, Vliegenthart JF. 1996. Structural studies of the exopolysaccharide produced by Lactobacillus paracasei 34-1. Carbohydr Res 285:129-139
26. Vanhaverbeke C, Bosso C, Colin-Morel P, Gey C, Gamar-Nourani L, Blondeau K, Simonet JM, Heyraud A. 1998. Structure of an extracellular polysaccharide produced by Lactobacillus rhamnosus strain C83. Carbohydr Res 314:211-220. https://doi.org/10.1016/S0008-6215 (98)00297-3
27. Gorska S, Schwarzer M, Jachymek W, Srutkova D, Brzozowska E, Kozakova H, Gamian A. 2014. Distinct immunomodulation of bone marrowderived dendritic cell responses to Lactobacillus plantarum WCFS1 by two different polysaccharides isolated from Lactobacillus rhamnosus LOCK 0900. Appl Environ Microbiol 80:6506-6516. https://doi.org/10.1128/AEM.02104-14
28. Gorska-Fraczek S, Sandstrom C, Kenne L, Rybka J, Strus M, Heczko P, Gamian A. 2011. Structural studies of the exopolysaccharide consisting of a nonasaccharide repeating unit isolated from Lactobacillus rhamnosus KL37B. Carbohydr Res 346:2926-2932. https://doi.org/10.1016/j.carres.2011.10.024
29. Harutoshi T. 2013. Exopolysaccharides of lactic acid bacteria for food and colon health applications, chapter 22. In Kongo JM (ed), Lactic acid bacteria-R & D for food, health and livestock purposes. InTech https://doi.org/10.5772/50839
30. Ciszek-Lenda M, Nowak B, Srottek M, Gamian A, Marcinkiewicz J. 2011. Immunoregulatory potential of exopolysaccharide from Lactobacillus rhamnosus KL37: effects on the production of inflammatory mediators by mouse macrophages. Int J Exp Pathol 92:382-391. https://doi.org/10.1111/j.1365-2613.2011.00788.x
31. Gao K, Wang C, Liu L, Dou X, Liu J, Yuan L, Zhang W, Wang H. 14 May 2015 Immunomodulation and signaling mechanism of Lactobacillus rhamnosus GG and its components on porcine intestinal epithelial cells stimulated by lipopolysaccharide. J Microbiol Immunol Infect https://doi.org/10.1016/j.jmii.2015.05.002
32. Patten DA, Laws AP. 2015. Lactobacillus-produced exopolysaccharides and their potential health benefits: a review. Benef Microbes 6:457-471. https://doi.org/10.3920/BM2014.0117
33. Vinderola G, Perdigon G, Duarte J, Farnworth E, Matar C. 2006. Effects of the oral administration of the exopolysaccharide produced by Lactobacillus kefiranofaciens on the gut mucosal immunity. Cytokine 36: 254-260. https://doi.org/10.1016/j.cyto.2007.01.003
34. Chanput W, Mes JJ, Wichers HJ. 2014. THP-1 cell line: an in vitro cell model for immune modulation approach. Int Immunopharmacol 23: 37-45. https://doi.org/10.1016/j.intimp.2014.08.002
35. Miettinen M, Lehtonen A, Julkunen I, Matikainen S. 2000. Lactobacilli and streptococci activate NF-κB and STAT signaling pathways in human macrophages. J Immunol 164:3733-3740. https://doi.org/10.4049/jimmunol.164.7.3733
36. Habil NY. 2015. Probiotic induce macrophage cytokine production via activation of STAT-3 pathway. Automat Control Intellig Syst 3:1-7
37. Zlotnik A, Yoshie O. 2000. Chemokines: a new classification system and their role in immunity. Immunity 12:121-127. https://doi.org/10.1016/S1074-7613(00)80165-X
38. Harant H, Eldershaw SA, Lindley IJ. 2001. Human macrophage inflammatory protein-3α/CCL20/LARC/Exodus/SCYA20 is transcriptionally upregulated by tumor necrosis factor-alpha via a non-standard NF-κB site. FEBS Lett 509:439-445. https://doi.org/10.1016/S0014-5793(01)03138-6
39. Veckman V, Miettinen M, Matikainen S, Lande R, Giacomini E, Coccia EM, Julkunen I. 2003. Lactobacilli and streptococci induce inflammatory chemokine production in human macrophages that stimulates Th1 cell chemotaxis. J Leukoc Biol 74:395-402. https://doi.org/10.1189/jlb.0402212
40. Chabot S, Yu H-L, Léséleuc LD, Cloutier D, Van Calsteren M-R, Lessard M, Roy D, Lacroix M, Oth D. 2001. Exopolysaccharides from Lactobacillus rhamnosus RW-9595M stimulate TNF. Lait 81:683-697. https://doi.org/10.1051/lait:2001157
41. Jorjao AL, de Oliveira FE, Leao MV, Carvalho CA, Jorge AO, de Oliveira LD. 2015. Live and heat-killed Lactobacillus rhamnosus ATCC 7469 may induce modulatory cytokines profiles on macrophages RAW 264.7. ScientificWorldJournal 2015:716749. https://doi.org/10.1155/2015/716749
42. Lebeer S, Claes IJ, Verhoeven TL, Vanderleyden J, De Keersmaecker SC. 2011. Exopolysaccharides of Lactobacillus rhamnosus GG form a protective shield against innate immune factors in the intestine. Microb Biotechnol 4:368-374. https://doi.org/10.1111/j.1751-7915.2010.00199.x
43. Yasuda E, Serata M, Sako T. 2008. Suppressive effect on activation of macrophages by Lactobacillus casei strain Shirota genes determining the synthesis of cell wall-associated polysaccharides. Appl Environ Microbiol 74:4746-4755. https://doi.org/10.1128/AEM.00412-08
44. Guglielmetti S, Balzaretti S, Taverniti V, Miriani M, Milani C, Scarafoni A, Corona S, Ciranna A, Arioli S, Santala V, Iametti S, Bonomi F, Ventura M, Mora D, Karp M. 2014. TgaA, a VirB1-like component belonging to a putative type IV secretion system of Bifidobacterium bifidum MIMBb75. Appl Environ Microbiol 80:5161-5169. https://doi.org/10.1128/AEM.01413-14
45. Alikhan NF, Petty NK, Ben Zakour NL, Beatson SA. 2011. BLAST Ring Image Generator (BRIG): simple prokaryote genome comparisons. BMC Genomics 12:402. https://doi.org/10.1186/1471-2164-12-402
46. Patten DA, Leivers S, Chadha MJ, Maqsood M, Humphreys PN, Laws AP, Collett A. 2014. The structure and immunomodulatory activity on intestinal epithelial cells of the EPSs isolated from Lactobacillus helveticus sp. Rosyjski and Lactobacillus acidophilus sp. 5e2. Carbohydr Res 384: 119-127. https://doi.org/10.1016/j.carres.2013.12.008
47. Gerwig GJ, Kamerling JP, Vliegenthart JFG. 1979. Determination of the absolute configuration of mono-saccharides in complex carbohydrates by capillary G.L.C. Carbohydr Res 77:1-7. https://doi.org/10.1016/S0008-6215(00)83788-X
48. Ciucanu I, Kerek F. 1984. A simple and rapid method for the permethylation of carbohydrates. Carbohydr Res 131:209-217
49. Guglielmetti S, Taverniti V, Minuzzo M, Arioli S, Stuknyte M, Karp M, Mora D. 2010. Oral bacteria as potential probiotics for the pharyngeal mucosa. Appl Environ Microbiol 76:3948-3958. https://doi.org/10.1128/AEM.00109-10
50. Stuknyte M, De Noni I, Guglielmetti S, Minuzzo M, Mora D. 2011. Potential immunomodulatory activity of bovine casein hydrolysates produced after digestion with proteinases of lactic acid bacteria. Int Dairy J 21:763-769. https://doi.org/10.1016/j.idairyj.2011.04.011
51. Tsuchiya S, Yamabe M, Yamaguchi Y, Kobayashi Y, Konno T, Tada K. 1980. Establishment and characterization of a human acute monocytic leukemia cell line (THP-1). Int J Cancer 26:171-176. https://doi.org/10.1002/ijc.2910260208
52. Traore K, Trush MA, George M, Jr, Spannhake EW, Anderson W, Asseffa A. 2005. Signal transduction of phorbol 12-myristate 13-acetate (PMA)-induced growth inhibition of human monocytic leukemia THP-1 cells is reactive oxygen dependent. Leuk Res 29:863-879. https://doi.org/10.1016/j.leukres.2004.12.011
53. Taverniti V, Minuzzo M, Arioli S, Junttila I, Hamalainen S, Turpeinen H, Mora D, Karp M, Pesu M, Guglielmetti S. 2012. In vitro functional and immunomodulatory properties of the Lactobacillus helveticus MIMLh5-Streptococcus salivarius ST3 association that are relevant to the development of a pharyngeal probiotic product. Appl Environ Microbiol 78: 4209-4216. https://doi.org/10.1128/AEM.00325-12